Allergy Therapeutics plc (AIM: AGY)
London
· Delayed Price · Currency is GBP · Price in GBX 7.10
-0.60 (-7.79%)
Jan 22, 2025, 12:39 PM GMT+1
Allergy Therapeutics Revenue
In the fiscal year ending June 30, 2024, Allergy Therapeutics had annual revenue of 55.20M GBP, down -7.36%. Allergy Therapeutics had revenue of 21.63M in the half year ending June 30, 2024, a decrease of -10.16%.
Revenue
55.20M
Revenue Growth
-7.36%
P/S Ratio
5.22
Revenue / Employee
90.19K
Employees
612
Market Cap
367.77M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 55.20M | -4.39M | -7.36% |
| Jun 30, 2023 | 59.59M | -13.18M | -18.11% |
| Jun 30, 2022 | 72.77M | -11.56M | -13.71% |
| Jun 30, 2021 | 84.33M | 6.13M | 7.83% |
| Jun 30, 2020 | 78.20M | 4.49M | 6.09% |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 38.20B |
| GSK plc | 31.31B |
| Haleon | 11.24B |
| Smith & Nephew | 4.46B |
| ConvaTec Group | 1.74B |
| Hikma Pharmaceuticals | 2.39B |
| HUTCHMED (China) | 483.31M |
| Oxford Nanopore Technologies | 167.75M |
Allergy Therapeutics News
- 4 weeks ago - SMALL CAP IDEA: Allergy Therapeutics transformation has redefined its trajectory - This is Money
- 7 months ago - Global Allergy Therapeutics Market Size To Exceed USD 42.5 Billion By 2033 | CAGR Of 6.29% - GlobeNewsWire
- 3 years ago - Allergy Therapeutics announces FDA clearance of IND application for novel peanut allergy vaccine candidate VLP Peanut - GlobeNewsWire
- 4 years ago - Allergy Therapeutics reports a 6% annualised growth in revenue in fiscal 2020 - Invezz